Header Logo

Connection

Jeffrey Borgia to Neoplasms, Experimental

Back to Details
This is a "connection" page, showing publications Jeffrey Borgia has written about Neoplasms, Experimental.
Jeffrey Borgia
Connection Strength
0.042
Neoplasms, Experimental
  1. CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC. Cancer Res. 2019 09 01; 79(17):4439-4452.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.